ClinicalTrials.Veeva

Menu

Risk of COVID-19 Infection After Vaccination

U

Umeå University

Status

Unknown

Conditions

Covid19
Vaccination; Infection

Treatments

Other: The COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1

Study type

Observational

Funder types

Other

Identifiers

NCT04848441
VACC-COV-19

Details and patient eligibility

About

The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.

Enrollment

2,000,000 estimated patients

Sex

All

Ages

Under 110 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Living in Sweden and vaccinated with BNT162b2, mRNA-1273 or ChAdOx1
  • All individuals with a previous COVID-19 infection
  • Controls matched 1:1 to the groups above

Exclusion criteria

  • None

Trial contacts and locations

0

Loading...

Central trial contact

Peter Nordström, Prof; Marcel Ballin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems